Diametric Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Diametric Capital's LKFT Position: Q3 2026 in Review
Diametric Capital opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 19,587 shares worth $581K. The stake represents 0.05% of the portfolio and ranks #333 among its holdings.
95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- Diametric Capital held 19,587 shares of Lakefront Biotherapeutics American Depositary Shares worth $581K as of Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares was a new Diametric Capital position in Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares made up 0.05% of Diametric Capital's portfolio in Q3 2026, its #333 holding.
- 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on Diametric Capital's 13F filing for Q3 2026, filed 16 Nov 2026.